Literature DB >> 19293039

Predicting factors in the last week of survival in elderly patients with terminal cancer: a prospective study in southern Taiwan.

Yee-Hsin Kao1, Cheng-Nan Chen, Jui-Kun Chiang, Shin-Shin Chen, Wen-Wei Huang.   

Abstract

BACKGROUND/
PURPOSE: The proportion of elderly persons among terminal cancer patients is around 60% in Taiwan. Prediction of the last week of survival can be significant in palliative care units for planning patient management, fulfilling patients' wishes at the end of life, and meeting the needs of relatives. We aimed to find out the predictive factors for the last week of survival in elderly terminal cancer patients.
METHODS: We prospectively observed items based on previous research that we anticipated might influence survival among 459 consecutive elderly patients. Within 24 hours of admission, we collected data including clinical symptoms and signs, demographic information, and biochemical test results. Multivariate logistic regression analysis was performed to identify factors associated with patient mortality within 7 days.
RESULTS: Multivariate analysis indicated that the following factors were predictive of death: higher score of Eastern Cooperative Oncology Group (ECOG) performance status (OR, 2.018; p < 0.001), primary liver cancer (OR, 1.968; p = 0.024), male gender (OR, 2.885; p < 0.001), lower extremity muscle power (OR, 0.722; p = 0.0266), lower systolic blood pressure (OR, 0.985; p = 0.011), higher heart rate (OR, 1.017; p = 0.016), higher hemoglobin (OR, 1.216; p = 0.003), and higher blood urea nitrogen (BUN) (OR, 1.028; p < 0.001).
CONCLUSION: We propose that the probability of survival of less than a week can be predicted by our formula. This formula, which includes factors of demographic information (male gender, and presence of liver cancer), clinical signs (lower systolic blood pressure, higher heart rate, and lower mean extremity muscle power), and biochemical tests (elevated BUN, and higher hemoglobin), may help improve survival prediction in terminal elderly cancer patients.

Entities:  

Mesh:

Year:  2009        PMID: 19293039     DOI: 10.1016/S0929-6646(09)60057-7

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  6 in total

1.  Impact of combined hospice care on terminal cancer patients.

Authors:  Song-Seng Loke; Kung-Ming Rau; Chih-Fang Huang
Journal:  J Palliat Med       Date:  2011-04-19       Impact factor: 2.947

2.  Helical tomotherapy for single and multiple liver tumours.

Authors:  Tsair-Fwu Lee; Pei-Ju Chao; Fu-Min Fang; Te-Jen Su; Stephen W Leung; Hsuan-Chih Hsu
Journal:  Radiat Oncol       Date:  2010-06-24       Impact factor: 3.481

3.  Variations in vital signs in the last days of life in patients with advanced cancer.

Authors:  Sebastian Bruera; Gary Chisholm; Renata Dos Santos; Camila Crovador; Eduardo Bruera; David Hui
Journal:  J Pain Symptom Manage       Date:  2014-04-14       Impact factor: 3.612

4.  The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non-wearable monitor.

Authors:  Haruka Tanaka; Sakiko Fukui; Isseki Maeda; Yutaka Hatano; Akari Higuchi; Yoko Higami; Miyae Yamakawa; Momoe Utsumi
Journal:  Cancer Med       Date:  2021-11-29       Impact factor: 4.452

5.  Cost-saving prediction model of transfer to palliative care for terminal cancer patients in a Japanese general hospital.

Authors:  Yuki Hashimoto; Akitoshi Hayashi; Takashi Tonegawa; Lida Teng; Ataru Igarashi
Journal:  J Mark Access Health Policy       Date:  2022-03-27

6.  Assessment of knowledge, accessibility and utilization of palliative care services among adult cancer patients at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia, 2014: a cross-sectional institution based study.

Authors:  Serawit Lakew; Hasna Musema; Tsehay Shimeles; Julia Challinor
Journal:  BMC Res Notes       Date:  2015-11-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.